Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Effectiveness of a Smartphone Chatbot to Improve Exercise Adherence in Older Adults (EXEBOT)

30 ottobre 2026 aggiornato da: CARMEN GARCÍA GOMARIZ, University of Valencia

Effectiveness of a Smartphone-Based Chatbot on Adherence to a Home-Based Multicomponent Exercise Program and Physical Function in Older Adults: A Randomized Controlled Trial

This randomized controlled trial aims to evaluate the effectiveness of a smartphone-based chatbot in improving adherence to a 12-week home-based multicomponent exercise program in community-dwelling older adults. Participants will be randomly assigned to receive either a chatbot-supported exercise program delivered through Telegram or an equivalent paper-based exercise program. Both groups will perform the same exercise program, including strength, balance, flexibility, and walking exercises. The primary outcome is exercise adherence. Secondary outcomes include physical function, physical activity, participant satisfaction, usability of the chatbot, and adverse events. The study seeks to determine whether chatbot-based support can enhance adherence and improve health outcomes in older adults.

Panoramica dello studio

Descrizione dettagliata

Population aging is associated with declines in physical function, mobility, and independence. Home-based multicomponent exercise programs are effective strategies to maintain physical function and reduce the risk of disability in older adults; however, adherence to exercise programs remains a major challenge, particularly when exercises are performed without direct supervision. Effectiveness of a Smartphone-Based Chatbot on Adherence to a Home-Based Multicomponent Exercise Program and Physical Function in Older Adults: A Randomized Controlled Trial addresses this challenge by evaluating a digital intervention specifically designed to support exercise adherence.

This study is a two-arm, parallel-group randomized controlled trial conducted in community-dwelling adults aged 60 years and older. Participants are randomly allocated in a 1:1 ratio to either a chatbot-supported exercise program or a paper-based exercise program. Both groups receive the same 12-week home-based multicomponent exercise program, consisting of three exercise sessions per week. The intervention includes strength, balance, flexibility, and walking exercises with a predefined progression throughout the program.

Participants assigned to the intervention group receive exercise prescriptions through a Telegram-based chatbot. In addition to delivering the exercise program, the chatbot provides instructional videos, automated reminders, exercise monitoring, adherence tracking, scheduling adjustments, and feedback based on participants' reported exercise completion. Participants allocated to the control group receive the same exercise program in a printed booklet together with a paper calendar for recording completed sessions. Both groups receive standardized follow-up telephone calls during the intervention period.

The primary outcome is exercise adherence, defined as the percentage of prescribed exercise sessions completed during the 12-week intervention. Participants are also classified according to whether they achieve at least 80% adherence to the prescribed sessions. Secondary outcomes include physical function assessed using the Short Physical Performance Battery (SPPB), 4-meter walking test, Five Times Sit-to-Stand Test (FTSST), and Timed Up and Go (TUG) test. Additional outcomes include physical activity measured with the International Physical Activity Questionnaire for Older Adults (IPAQ-E), participant satisfaction, perceived usability of the chatbot, and adverse events.

The study will provide evidence regarding the effectiveness of chatbot-supported exercise interventions for promoting adherence to home-based exercise programs among older adults. If effective, this approach may represent a scalable and accessible strategy to support healthy aging and the implementation of exercise programs in community settings.

Tipo di studio

Interventistico

Iscrizione (Stimato)

100

Fase

  • Non applicabile

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 59 anni a 85 anni (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Community-dwelling adults aged 60 years or older.
  • Living independently in the community.
  • Ownership and regular use of a smartphone.
  • Familiarity with at least one instant messaging application and ability to access it at least three times per week.
  • Ability to understand study procedures and instructions.
  • Ability to provide written informed consent.
  • Ability to safely perform a home-based exercise program.

Exclusion Criteria:

  • Absolute contraindication to physical exercise.
  • Inability to understand study instructions.
  • Inability to read and/or write.
  • Uncontrolled neurological conditions that may compromise safe participation in exercise.
  • Uncontrolled cardiovascular conditions that may compromise safe participation in exercise.
  • Any medical condition judged by the investigators to prevent safe participation in the study.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Chatbot-Supported Exercise Program

Participants will receive a 12-week home-based multicomponent exercise program delivered through a Telegram-based chatbot. The program includes three exercise sessions per week consisting of strength, balance, flexibility, and walking exercises with a predefined progression. The chatbot provides exercise prescriptions, instructional videos, reminders, monitoring of exercise completion, scheduling adjustments, and automated feedback to support adherence.

A 12-week home-based multicomponent exercise program delivered through a Telegram-based chatbot. The program includes strength, balance, flexibility, and walking exercises performed three times per week. The chatbot provides exercise prescriptions, instructional videos, automated reminders, adherence monitoring, scheduling adjustments, and feedback to support exercise participation.

Altri nomi:
  • Telegram-Based Exercise Chatbot
Comparatore attivo: Paper-Based Exercise Program

Participants will receive a 12-week home-based multicomponent exercise program in a printed booklet. The program includes three exercise sessions per week consisting of strength, balance, flexibility, and walking exercises with a predefined progression. Participants will also receive a paper calendar to record exercise completion. No chatbot-based reminders, monitoring, or automated feedback will be provided. Participants will receive the same exercise content, dosage, and progression as the experimental group.

A 12-week home-based multicomponent exercise program delivered in a printed booklet. The program includes strength, balance, flexibility, and walking exercises performed three times per week with the same content and progression as the experimental intervention. Participants record exercise completion using a paper calendar and do not receive chatbot-based reminders, monitoring, or feedback.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Exercise Adherence
Lasso di tempo: 12 weeks

Exercise adherence will be measured as the percentage of the 36 prescribed exercise sessions completed during the 12-week intervention period. Adherence will be calculated from participant exercise records and expressed as a continuous percentage value.

12 weeks

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Adherent Participants
Lasso di tempo: 12 weeks

Number and proportion of participants completing at least 80% of the prescribed exercise sessions during the intervention period.

12 weeks
Short Physical Performance Battery (SPPB)
Lasso di tempo: Baseline and 12 weeks

Physical function assessed using the Short Physical Performance Battery. Scores range from 0 to 12, with higher scores indicating better physical performance.

Baseline and 12 weeks
Timed Up and Go Test (TUG)
Lasso di tempo: Baseline and 12 weeks

Mobility assessed as the time required to stand up from a chair, walk 3 meters, turn, return, and sit down.

Baseline and 12 weeks
Physical Activity Level
Lasso di tempo: Baseline and 12 weeks

Physical activity will be assessed using the International Physical Activity Questionnaire for the Elderly (IPAQ-E). Physical activity is quantified as MET-minutes per week (MET-min/week), calculated from the frequency and duration of walking, moderate-intensity, and vigorous-intensity physical activities performed during the previous week. The questionnaire does not have a predefined minimum or maximum score, as results are reported as a continuous measure of energy expenditure. A practical minimum score is 0 MET-min/week, while no upper limit is defined. Higher scores indicate higher levels of physical activity and therefore a better outcome.

Baseline and 12 weeks
Participant Satisfaction
Lasso di tempo: 12 weeks

Participant satisfaction with the intervention will be assessed using the Client Satisfaction Questionnaire-8 (CSQ-8). The CSQ-8 consists of 8 items, each scored on a 4-point Likert scale. Total scores range from 8 to 32 points, with higher scores indicating greater satisfaction with the intervention and therefore a better outcome.

12 weeks
Chatbot Usability
Lasso di tempo: 12 weeks

Perceived usability of the chatbot will be assessed using the System Usability Scale (SUS). The SUS is a 10-item questionnaire with responses scored on a 5-point Likert scale. Total scores range from 0 to 100, with higher scores indicating better perceived usability of the chatbot and therefore a better outcome. This outcome will be assessed only in participants allocated to the chatbot intervention group.

12 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

14 dicembre 2026

Completamento primario (Stimato)

30 gennaio 2027

Completamento dello studio (Stimato)

30 gennaio 2027

Date di iscrizione allo studio

Primo inviato

15 settembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

15 settembre 2026

Primo Inserito (Effettivo)

21 settembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

2 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

30 ottobre 2026

Ultimo verificato

1 ottobre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • BOT_01

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi